Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr.Reddy's Laboratories reports 11% rise in Q3 consolidated net profit

Date: 31-01-2024

Dr. Reddy's Laboratories has reported results for third quarter ended December 31, 2023 (Q3FY24). 

The company has reported 46.40% rise in net profit at Rs 475.20 crore for the third quarter ended December 31, 2023 as compared to Rs 324.60 crore for the same quarter in the previous year. Total income of the company increased by 9.66% at Rs 4330.60 crore for Q3FY24 as compared Rs 3949.00 crore for corresponding quarter of the previous year.

On consolidated basis, the company reported 11.01% rise in its net profit at Rs 1380.90 crore for Q3FY24 as compared to Rs 1243.90 crore for the same quarter in the previous year. Total income of the company increased by 8.83% at Rs 7453.00 crore for Q3FY24 as compared Rs 6848.50 crore for corresponding quarter of the previous year.